Dimensional Fund Advisors
AURA icon

Dimensional Fund Advisors’s Aura Biosciences AURA Stock Holding History

Dimensional Fund Advisors’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.45M Buy
708,950
+90,059
+15% +$644K ﹤0.01% 2528
2026
Q2 		$4.39M Buy
618,891
+60,733
+11% +$435K ﹤0.01% 2573
2026
Q1 		$3.73M Buy
558,158
+40,242
+8% +$231K ﹤0.01% 2579
2025
Q4 		$2.82M Buy
517,916
+20,641
+4% +$123K ﹤0.01% 2662
2025
Q3 		$3.07M Buy
497,275
+41,118
+9% +$269K ﹤0.01% 2657
2025
Q2 		$2.86M Buy
456,157
+50,231
+12% +$294K ﹤0.01% 2666
2025
Q1 		$2.38M Buy
405,926
+40,102
+11% +$303K ﹤0.01% 2686
2024
Q4 		$3.01M Buy
365,824
+73,062
+25% +$688K ﹤0.01% 2682
2024
Q3 		$2.61M Buy
292,762
+42,387
+17% +$363K ﹤0.01% 2719
2024
Q2 		$1.89M Buy
250,375
+41,711
+20% +$306K ﹤0.01% 2770
2024
Q1 		$1.64M Buy
208,664
+30,946
+17% +$257K ﹤0.01% 2830
2023
Q4 		$1.58M Buy
177,718
+66,178
+59% +$560K ﹤0.01% 2837
2023
Q3 		$1M Buy
111,540
+71,520
+179% +$769K ﹤0.01% 2928
2023
Q2 		$494K Buy
+40,020
New +$428K ﹤0.01% 3064

Other funds holding AURA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Medicxi Ventures Management
Medicxi Ventures Management St. Helier, Jersey $127M AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Levin Capital Strategies
Levin Capital Strategies New York $1.42B AUM 19.05% 1-Year Est. Return

Dimensional Fund Advisors's AURA Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Aura Biosciences (AURA) stake by 15% in Q3 2026, buying an estimated $644K and bringing the position to 708,950 shares worth $4.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2528.

Dimensional Fund Advisors first reported a position in AURA in Q2 2023 and has held it in 14 quarters since. 98 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • Dimensional Fund Advisors held 708,950 shares of Aura Biosciences worth $4.45M as of Q3 2026.
  • Dimensional Fund Advisors bought 90,059 Aura Biosciences shares in Q3 2026, an estimated $644K.
  • Aura Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2528 holding.
  • Dimensional Fund Advisors first reported a position in Aura Biosciences in Q2 2023 and has held it in 14 quarters since.
  • 98 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.